Vaginal progesterone does not prevent recurrent preterm birth in women with a singleton gestation, a history of spontaneous preterm birth, and a midtrimester cervical length >25 mm-Reference-Cited by-同舟云学术

Vaginal progesterone does not prevent recurrent preterm birth in women with a singleton gestation, a history of spontaneous preterm birth, and a midtrimester cervical length >25 mm

Published:2022-12 Issue:6 Volume:227 Page:923-926
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Conde-Agudelo Agustin,Romero Roberto^ORCID

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference9 articles.

1. Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a systematic review and meta-analysis;Conde-Agudelo;Am J Obstet Gynecol,2022

2. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data;Romero;Am J Obstet Gynecol,2018

3. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis;Conde-Agudelo;Am J Obstet Gynecol,2018

4. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial;O’Brien;Ultrasound Obstet Gynecol,2007

5. Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial;Cetingoz;Arch Gynecol Obstet,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polycystic ovary syndrome and miscarriage: a narrative review;F&S Reviews;2024-10

2. Concurrent progestogen and cerclage to reduce preterm birth: a multicenter international retrospective cohort;American Journal of Obstetrics & Gynecology MFM;2024-07

3. The end is where we start from: withdrawal of 17-alpha hydroxyprogesterone caproate to prevent recurrent preterm birth;American Journal of Obstetrics and Gynecology;2024-01

4. Vaginal progesterone should be offered to patients with a singleton gestation and a history of spontaneous preterm birth only if a cervical length ≤25 mm is detected at midtrimester;American Journal of Obstetrics & Gynecology MFM;2024-01

5. New medicines for spontaneous preterm birth prevention and preterm labour management: landscape analysis of the medicine development pipeline;BMC Pregnancy and Childbirth;2023-07-18